Apyx Medical Corporation - Common Stock (APYX)
4.4700
+0.1800 (4.20%)
NASDAQ· Last Trade: Jun 7th, 6:18 PM EDT
Babcock & Wilcox delivers energy and emissions control solutions to industrial and utility clients worldwide.
Via The Motley Fool · May 21, 2026
This cybersecurity firm delivers risk assessment and vulnerability management solutions to enterprise and government clients worldwide.
Via The Motley Fool · May 21, 2026
Oceaneering International delivers subsea robotics, engineered products, and digital solutions to global energy and defense clients.
Via The Motley Fool · May 21, 2026
APYX Medical Corp (NASDAQ:APYX) Meets Minervini Trend Template with High-Growth Momentumchartmill.com
Via Chartmill · March 24, 2026
EZCORP operates a broad network of pawn stores and digital platforms, serving consumers seeking short-term credit and value-priced goods.
Via The Motley Fool · May 21, 2026
Satellogic delivers real-time Earth observation data and analytics, serving commercial and government clients across multiple industries.
Via The Motley Fool · May 21, 2026
Apyx Medical (APYX) Q1 2026 Earnings Transcript
Via The Motley Fool · May 8, 2026
Apyx Medical Corp (NASDAQ:APYX) Reports Q4 Revenue Beat and Narrowed Losschartmill.com
Via Chartmill · March 10, 2026
Gapping stocks in Monday's sessionchartmill.com
Via Chartmill · March 23, 2026
As November 20, 2025, unfolds, global financial markets present a landscape of intriguing contrasts, marked by the persistent, transformative power of artificial intelligence and a growing undercurrent of investor caution. While select sectors and geographies celebrate robust growth fueled by technological advancements and strong earnings, broader market sentiment in key
Via MarketMinute · November 20, 2025
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · November 17, 2025
Apyx Medical Q3 2025 earnings beat expectations with a 50% EPS surprise and strong revenue. Stock surges on successful AYON Body Contouring System launch.
Via Chartmill · November 6, 2025
APYX Medical Corp reported Q2 2025 results with revenue of $11.37M, missing estimates, but a narrower EPS loss of -$0.09. Stock shows muted reaction amid commercial expansion plans.
Via Chartmill · August 7, 2025
Via Benzinga · June 23, 2025
Via Benzinga · May 14, 2025
Via Benzinga · May 13, 2025

APYX stock results show that Apyx Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 8, 2024

Via Benzinga · June 13, 2024

